Cargando…
Clinical Utility of Plasma Lipid Peroxidation Biomarkers in Alzheimer’s Disease Differential Diagnosis
Background: Differential diagnosis of Alzheimer’s disease (AD) is a complex task due to the clinical similarity among neurodegenerative diseases. Previous studies showed the role of lipid peroxidation in early AD development. However, the clinical validation of potential specific biomarkers in minim...
Autores principales: | Peña-Bautista, Carmen, Álvarez, Lourdes, Durand, Thierry, Vigor, Claire, Cuevas, Ana, Baquero, Miguel, Vento, Máximo, Hervás, David, Cháfer-Pericás, Consuelo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7464465/ https://www.ncbi.nlm.nih.gov/pubmed/32707935 http://dx.doi.org/10.3390/antiox9080649 |
Ejemplares similares
-
New screening approach for Alzheimer’s disease risk assessment from urine lipid peroxidation compounds
por: Peña-Bautista, Carmen, et al.
Publicado: (2019) -
Assessment of Lipid Peroxidation in Alzheimer’s Disease Differential Diagnosis and Prognosis
por: Ferré-González, Laura, et al.
Publicado: (2022) -
Lipid Peroxidation Assessment in Preclinical Alzheimer Disease Diagnosis
por: Peña-Bautista, Carmen, et al.
Publicado: (2021) -
Isoprostanoids Levels in Cerebrospinal Fluid Do Not Reflect Alzheimer’s Disease
por: Peña-Bautista, Carmen, et al.
Publicado: (2020) -
Early neurotransmission impairment in non-invasive Alzheimer Disease detection
por: Peña-Bautista, Carmen, et al.
Publicado: (2020)